BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 22908779)

  • 21. [Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts].
    Sivkov AV; Golovanov SA; Zhukova LV
    Urologiia; 2019 Jul; (3):14-22. PubMed ID: 31356008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.
    Saidi S; Stavridis S; Stankov O; Dohcev S; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):123-129. PubMed ID: 28991765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.
    Iacono F; Prezioso D; Illiano E; Ruffo A; Romeo G; Amato B
    BMC Surg; 2012; 12 Suppl 1(Suppl 1):S22. PubMed ID: 23173650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
    Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
    Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
    Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
    Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Novara G; Giannarini G; Alcaraz A; Cózar-Olmo JM; Descazeaud A; Montorsi F; Ficarra V
    Eur Urol Focus; 2016 Dec; 2(5):553-561. PubMed ID: 28723522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
    Plosker GL; Brogden RN
    Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.
    Marzano R; Dinelli N; Ales V; Bertozzi MA
    Arch Ital Urol Androl; 2015 Mar; 87(1):25-7. PubMed ID: 25847892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.
    Vinarov AZ; Spivak LG; Platonova DV; Rapoport LM; Korolev DO
    Urologia; 2019 Feb; 86(1):17-22. PubMed ID: 29741118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
    Argirović A; Argirović D
    Vojnosanit Pregl; 2013 Dec; 70(12):1091-6. PubMed ID: 24450252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
    Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
    Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
    Ooi SL; Pak SC
    J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
    Mantovani F
    Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study.
    Stamatiou K; Pierris N
    Arch Ital Urol Androl; 2013 Dec; 85(4):190-6. PubMed ID: 24399120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2002; (1):23-5. PubMed ID: 11877967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostamol-Uno treatment in patients with prostatic adenoma and chronic non-infectious prostatitis].
    Trapeznikova MF; Dutov VV; Dolgovq AG; Urenkov SB
    Urologiia; 2008; (5):39-42. PubMed ID: 19069494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.